Prior to her scientific training, Katia Nazmutdinova ran a video transfer services company in the States, which was sold for a profit in 2007 and exists to this day. She then studied human biology, while working part-time as a freelance writer, broadcast editor and a science tutor and obtained her MSci in Biological Sciences (UCL, 2013) and a PhD in Genetics of Rare Diseases (UCL, 2018). In her doctoral research she modelled a rare kidney disease using patient-derived cells, isolated from urine. There was huge potential in this new cell source and an opportunity to innovate, which resulted in Encelo, co-founded with Dr Natalie Grefenstette, who has a background in organic chemistry. Dr Katia Nazmutdinova is the driving force of Encelo, responsible for product development, the strategic direction of the company and liaising with prospective customers and partners.
Did you know?
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.